Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies
10.3390/biom12091261
Saved in:
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Language: | English |
| Published: |
MDPI
2022
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/234467 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-234467 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2344672024-11-09T12:58:12Z Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE Prof Wee Joo Chng Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology CD38 immunotherapy blood malignancies daratumumab drug combination extracellular vesicles miRNA CHRONIC LYMPHOCYTIC-LEUKEMIA MULTIPLE-MYELOMA CELLS T-CELL RETINOIC ACID OPEN-LABEL REGULATORY CELLS MUTATION STATUS FLOW-CYTOMETRY B-CLL EXPRESSION 10.3390/biom12091261 BIOMOLECULES 12 9 2022-11-14T03:34:28Z 2022-11-14T03:34:28Z 2022-09-01 2022-11-13T14:55:30Z Review Mustafa, Nurulhuda, Azaman, Muhamad Irfan, Ng, Giselle GK, Chng, Wee Joo (2022-09-01). Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies. BIOMOLECULES 12 (9). ScholarBank@NUS Repository. https://doi.org/10.3390/biom12091261 2218-273X https://scholarbank.nus.edu.sg/handle/10635/234467 en MDPI Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology CD38 immunotherapy blood malignancies daratumumab drug combination extracellular vesicles miRNA CHRONIC LYMPHOCYTIC-LEUKEMIA MULTIPLE-MYELOMA CELLS T-CELL RETINOIC ACID OPEN-LABEL REGULATORY CELLS MUTATION STATUS FLOW-CYTOMETRY B-CLL EXPRESSION |
| spellingShingle |
Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology CD38 immunotherapy blood malignancies daratumumab drug combination extracellular vesicles miRNA CHRONIC LYMPHOCYTIC-LEUKEMIA MULTIPLE-MYELOMA CELLS T-CELL RETINOIC ACID OPEN-LABEL REGULATORY CELLS MUTATION STATUS FLOW-CYTOMETRY B-CLL EXPRESSION Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
| description |
10.3390/biom12091261 |
| author2 |
MEDICINE |
| author_facet |
MEDICINE Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo |
| format |
Review |
| author |
Mustafa, Nurulhuda Azaman, Muhamad Irfan Ng, Giselle GK Chng, Wee Joo |
| author_sort |
Mustafa, Nurulhuda |
| title |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
| title_short |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
| title_full |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
| title_fullStr |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
| title_full_unstemmed |
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies |
| title_sort |
molecular determinants underlying the anti-cancer efficacy of cd38 monoclonal antibodies in hematological malignancies |
| publisher |
MDPI |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/234467 |
| _version_ |
1821199408874651648 |